Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Adenocarcinomas of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT03983954
What this trial is testing

Naptumomab Estafenatox in Combination With Durvalumab in Subjects With Selected Advanced or Metastatic Solid Tumor, Including a Cohort Expansion in Esophageal Cancer.

Who this might be right for
ER+ Breast CancerOvarian CancerCervical Squamous Cell Carcinoma+17 more
NeoTX Therapeutics Ltd. 120
Not applicableLooking for participantsNCT05053555
What this trial is testing

High Dose-Rate Brachytherapy for the Treatment of Both Primary and Secondary Unresectable Liver Malignancies

Who this might be right for
Liver Malignant TumorsCholangiocarcinoma MetastaticPancreatic Cancer+1 more
M.D. Anderson Cancer Center 60
Testing effectiveness (Phase 2)Study completedNCT00265876
What this trial is testing

AZD0530 and Gemcitabine in Locally Advanced/Metastatic Pancreatic Cancer That Cannot Be Removed By Surgery

Who this might be right for
Pancreatic Cancer
NCIC Clinical Trials Group 34
Early research (Phase 1)Study completedNCT04430842
What this trial is testing

Dose Escalation Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of QBS10072S

Who this might be right for
AstrocytomaBrain CancerBrain Metastases+20 more
Quadriga Biosciences, Inc. 15
Testing effectiveness (Phase 2)Study completedNCT00873353
What this trial is testing

Trial to Evaluate the Efficacy and Safety of Tarceva and Capecitabine in Advanced Pancreatic Cancer Patients

Who this might be right for
Metastatic Adenocarcinoma of the Pancreas
Grupo Gallego de Investigaciones Oncologicas 32
Post-approval studies (Phase 4)UnknownNCT01642875
What this trial is testing

Early Oral Versus Enteral Nutrition After Pancreatoduodenectomy

Who this might be right for
Pancreatic CancerCancer of the DuodenumCholangiocarcinoma+1 more
Medical University of Warsaw 96
Not applicableLooking for participantsNCT04037007
What this trial is testing

Efficacy of Fistulotomy for Biliary Cannulation

Who this might be right for
CholangiocarcinomaCholedocholithiasis; CholangitisPancreatic Cancer+1 more
Coordinación de Investigación en Salud, Mexico 320
Testing effectiveness (Phase 2)Active Not RecruitingNCT07777211
What this trial is testing

A Phase I/IIa Study of GKL-006 Injection in Patients With Advanced Pancreatic Cancer

Who this might be right for
Advanced Pancreatic CancerDuctal Adenocarcinoma of Pancreas
Beijing Gene Key Life Technology Co., Ltd 52
Early research (Phase 1)Looking for participantsNCT06562192
What this trial is testing

Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers

Who this might be right for
Pancreatic Ductal AdenocarcinomaNon-small Cell Lung CancerHR+/HER2- Ductal and Lobular Breast Cancer+2 more
Novartis Pharmaceuticals 162
Testing effectiveness (Phase 2)Looking for participantsNCT06821997
What this trial is testing

NALIRIFOX Before Surgery for the Treatment of Borderline Resectable Pancreatic Ductal Adenocarcinoma, Nectar Trial

Who this might be right for
Borderline Resectable Pancreatic Ductal Adenocarcinoma
Roswell Park Cancer Institute 20
Early research (Phase 1)Study completedNCT02030860
What this trial is testing

Neoadjuvant Paricalcitol to Target the Microenvironment in Resectable Pancreatic Cancer

Who this might be right for
Adenocarcinoma of the Pancreas
Abramson Cancer Center at Penn Medicine 15
Large-scale testing (Phase 3)Looking for participantsNCT06897644
What this trial is testing

Gemcitabine Plus Nab-paclitaxel as Switch Maintenance Versus Continuation of Modified FOLFIRINOX as 1st Line Chemotherapy in Patients With Advanced Pancreatic Cancer.

Who this might be right for
Pancreatic Adenocarcinoma Advanced or Metastatic
Gruppo Oncologico del Nord-Ovest 340
Early research (Phase 1)Study completedNCT00073944
What this trial is testing

BCX-1777 in Treating Patients With Refractory Cancer

Who this might be right for
Cancer
BioCryst Pharmaceuticals
Early research (Phase 1)Ended earlyNCT05983133
What this trial is testing

PF-08046052/SGN-EGFRd2 in Advanced Solid Tumors

Who this might be right for
Colorectal NeoplasmsCarcinoma, Non-Small-Cell LungSquamous Cell Carcinoma of the Head and Neck+1 more
Seagen, a wholly owned subsidiary of Pfizer 68
Very early researchNot Yet RecruitingNCT07781852
What this trial is testing

Evaluation of the Distribution of 64Cu/68Ga Labeled CM500 in Healthy Volunteers and Patients With Cancer

Who this might be right for
Bladder CancerGliomaGlioblastoma (GBM)+13 more
Lumina Pharmaceuticals Inc 40
Testing effectiveness (Phase 2)Looking for participantsNCT06907043
What this trial is testing

PARP1 Selective Inhibitor, EIK1004 (IMP1707) in Participants With Advanced Solid Tumors.

Who this might be right for
Advanced Solid Tumors
Eikon Therapeutics 130
Not applicableWithdrawnNCT04821219
What this trial is testing

Personalized Management of Pancreatic Adenocarcinoma Using Patient-Derived Tumoroids

Who this might be right for
Pancreas Adenocarcinoma
Mayo Clinic
Testing effectiveness (Phase 2)Active Not RecruitingNCT06921928
What this trial is testing

Study for AZD4360 in Participants With Advanced Solid Tumours

Who this might be right for
Gastric CancerGastroesophageal Junction CancerBiliary Tract Cancer+1 more
AstraZeneca 31
Very early researchEnded earlyNCT00867126
What this trial is testing

Pioglitazone as Second-Line in Patients With Metastatic Pancreatic Cancer After Treatment With Gemcitabine

Who this might be right for
Pancreatic Cancer
University of Texas Southwestern Medical Center 6
Early research (Phase 1)Active Not RecruitingNCT04477343
What this trial is testing

Evaluate the Safety and Tolerability of SX-682 in Combination With Nivolumab as a Maintenance Therapy in Patients With Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal AdenocarcinomaPancreatic Cancer
University of Rochester 20
Next Page